Phase II trial of tipelukast in non-alcoholic fatty liver disease (NAFLD)
Latest Information Update: 17 May 2023
At a glance
- Drugs Tipelukast (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- 14 May 2023 Status changed from planning to recruiting, according to a MediciNova media release.
- 19 Apr 2022 New trial record